drugset / Trial / NCT03578341

Oral Colostrum and Its Effect on Immune System

NCT03578341 ↗

RandomizedSequentialTriple-blindPrevention

Summary

The purpose of this project is to increase the serum immunological defenses of premature infants less then 32 weeks of gestation by administrating colostrum in the oropharyngeal mucosa versus placebo

Timeline

Start
2018-06-01
Primary completion
2019-10-30
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Colostrum Protein / enzyme biologic 0.3 ml Other